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Purpose: To report a patient with symptomatic intraocular pressure (IOP) elevation in an eye with 
neovascular glaucoma (NVG) during hemodialysis.
Methods: Case report.
Results: Recurrent episodes of severe ocular pain and elevated IOP in the NVG eye were noted during 
hemodialysis in a 29-year-old man. The patient was recently diagnosed at our ophthalmology clinic with NVG 
due to central retinal vein occlusion. IOP was temporarily controlled after the Ahmed valve implantation. 
However, after the fibrous membrane developed and occluded the tip of the Ahmed valve, IOP elevation 
during hemodialysis recurred. Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, 
topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing 
pain and IOP elevation. Eventually, evisceration and hydroxyappatite implantation were performed.
Conclusions: Physicians must be alert to the possibility of IOP elevation in glaucomatous eyes during 
hemodialysis.  Korean Journal of Ophthalmology 20(2):109-112, 2006
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Hemodialysis is performed to maintain patients with end 
stage renal disease, but there are still various complications 
which are associated with the procedure. Headache, nausea 
and fatigue sometimes develop in combination with the rise 
in intraocular pressure (IOP). An intradialytic increase in IOP 
was already reported in patients without glaucoma,
1-6 and 
marked IOP increases had been shown in patients suffering 
from glaucoma.
7-8 The mechanism that has been most widely 
proposed for this IOP increase is the movement of water 
from the plasma into the aqueous humour due to an osmotic 
disequilibrium between the two compartments caused by a 
rapid decrease in plasma osmolarity.
1-4 
 There have been studies on Korean nonglaucomatous 
patients with IOP elevations during hemodialysis and also on 
the medial control of intradialytic IOP elevation in Korean 
nonglaucomatous patients; but reports on glaucoma patients 
have been limited. We would like to report a neovascular 
glaucoma (NVG) patient with marked IOP elevation during 
hemodialysis who had been refractory to treatment.
Materials and Methods
On August 2, 2004, a 29-year-old Korean male visited our 
ophthalmology department due to decreased visual acuity of 
his right eye for one week before the visit. His visual acuities 
were decreased to Right: 20/60, Left: 20/1000, and his IOPs 
were within the normal range. His vision at his previous visit 
on February 11, 2004 was Right: 20/25 and Left: 20/200. On 
fundus examination and fluorescein angiogram, a new 
diagnosis of central retinal vein occlusion was made in his 
right eye. There was no definite neovascularization on fluo-
rescein angiogram and no relative afferent papillary defect 
(RAPD) at present. His left eye had showed old branch 
retinal vein occlusion with laser scars, which had been treated 
at our clinic two years before. He had end-stage renal failure 
due to Immunoglobulin A nephropathy, and he had begun 
regular hemodialysis at our hospital nephrology department in 
1993. He also had secondary hypertension and was on 
medication for this condition.
We prescribed oral fibrinolytics. Since the patient was 
young and the fellow eye had branch retinal vein occlusion, 
we planned a trans pars plana vitrectomy and a radial optic 
neurotomy of his right eye. While waiting for the operation 
on August 30, he visited our clinic complaining of severe Korean  J  Ophthalmol  Vol.20,  No.2,  2006
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Fig. 1. Intraocular  pressure  shifts  according  to  dates  and  events.
Intraocular  pressures  were  checked  by  Goldmann  applanation  tonometry  (mmHg).  *ACP=anterior  chamber  paracentesis; 
†HD  =hemo-
dialysis; 
‡5-FU=subconjuctival  5-fluorouracil  injection; 
§man  400=intravenous  mannitolization  400  cc;  OD=right  eye;  OS  =left  eye.
Intraocular  pressure  of  the  NVG  eye  (right  eye)  of  the  patient  showed  a  marked  increase  after  hemodialysis  (p=0.028).  The  intraocular 
pressure  of  the  left  eye  remained  within  the  normal  range  without  statistical  change  regarding  hemodialysis  (p=0.066).
ocular pain. Unfortunately his visual acuity had dropped to 
light perception, the IOP of his right eye was 48 mmHg, and 
360 degrees of neovascularization of the iris was observed. 
On gonioscopic examination, crowded new vessels were seen 
at 360 degrees of the open angle. The patient was diagnosed 
as NVG due to ischemic type central retinal vein occlusion. 
The patient was prospectively examined.
Results
On August 30, when first diagnosed as NVG, the patient򰡑
s IOP was lowered to 4 mmHg by anterior chamber 
paracentesis. Anterior chamber paracentesis was chosen as an 
initial treatment in order to minimize metabolic complications 
that might have been accompanied by aggressive mannitoli-
zation or high-dose oral acetazolamide medication. Topical 
β -blocker, a carbonic anhydrase inhibitor combination 
(Cosopt
Ⓡ),  α -agonist (Alphagan
Ⓡ), prostaglandin analogue 
(Travatan
Ⓡ) and oral acetazolamide (Diamox
Ⓡ) 125 mg four 
times a day were prescribed. However, a few hours later he 
visited our emergency department suffering throbbing ocular 
pain during hemodialysis and his IOP was 38 mmHg. Severe 
ocular pain during hemodialysis also developed on September 
1, and the IOP of his right eye was 46 mmHg. The IOP was 
lowered to 16 mmHg by anterior chamber paracentesis, but 
a 1.5-mm high hyphema developed. Ahmed valve implan-
tation was done on September 2. The IOP was managed at 
a normal range until 19 days postoperatively. 
On the 20
th day postoperatively, the IOP of his right eye 
was 35 mmHg following hemodialysis, and was normalized 
by anterior chamber paracentesis and subconjunctival 5- 
fluorouracil (5-FU) injection. Gross hyphema developed after 
the injection which prevented examination of the status of the 
anterior chamber. On September 24, his IOP was 28 mmHg 
before hemodialysis, but on the same day he suffered severe 
ocular pain and his IOP was elevated to 48 mmHg after 
hemodialysis. Since the IOP elevation and pain usually 
happened in the afternoon following hemodialysis, we 
decided to check his IOP both before and after the hemo-
dialysis.
From September 24 through October 6, the mean IOP 
difference of the patient’s NVG eye before and after 
hemodialysis was 26 mmHg, and the difference showed 
statistical significance (SPSS version 11.5, Nonparametric 
Wilcoxon signed ranks test; p=0.028) (Fig. 1). The IOP of 
the fellow eye remained in the normal range without a 
statistical shift regarding the hemodialysis (p=0.066) (Fig. 1). 
To stop the vicious cycle, we checked and controlled his IOP 
before starting hemodialysis and also mixed 300-400 cc of 
25% mannitol during the hemodialysis. His IOP was 
successfully controlled by this method for ten days thereafter.
By October 18, the hyphema was much improved but a 
fibrous membrane occluding the Ahmed valve tip developed 
and the IOP began to rise again. A Neodymium: YAG laser 
at the fibrous membrane and a subconunctival 5-FU injection 
were performed but failed to control the IOP. On behalf of 
many trials the patient had recurrent ocular pain attacks and 
nonclearing hyphema, and his IOP was around 50 mmHg 
with no response to treatment. On November 18, evisceration 
and hydroxyappatite implantation were performed.WK  Song,  et  al.  INTRAOCULAR  PRESSURE  AND  HEMODIALYSIS 
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Discussion
Intradialytic IOP elevation can occur, and there have 
already been several reports on this issue. It has been 
reported in patients without glaucoma
1-6 and also in patients 
suffering from glaucoma.
7-8 Jung et al.
5 found IOP elevation 
after hemodialysis in Korean nonglaucomatous patients. IOP 
fluctuation is more harmful in glaucoma patients, and since 
reports on IOP fluctuations in glaucoma patients during 
hemodialysis have been limited, we decided to present this 
case.
There have been many mechanisms reported to explain this 
phenomenon. The most common is that the rise in IOP may 
be the result of a rapid fall in plasma osmolarity with 
a consequent increase in aqueous formation: a mechanism 
analogous to the cerebral edema that occurs in the disequi-
librium syndrome. This relation between plasma osmolarity 
and IOP during hemodialysis has been studied since the 
report of Sitprija and coworkers.
9-11 They first discovered that 
a rapid decrease in plasma osmolarity caused markedly 
increased IOP levels during hemodialysis. However there is 
conflicting evidence about the rate of an osmolarity decrease 
that can induce an increase in IOP during hemodialysis. In 
addition, Hojs and Pahor
12 could not find statistically 
significant differences in IOP either before or after hemo-
dialysis even though osmolarity changes were present. They 
insisted that with modern techniques of hemodialysis, a rise 
in IOP might be unlikely. Tokuyama et al.
13 even reported 
a decrease in IOP after hemodialysis, and also that IOP 
change had inverse correlation with the increase in plasma 
colloid osmotic pressure caused by the removal of fluid 
during the hemodialysis.
Some have suggested that decreased aqueous outflow 
might be the mechanism of an intradialytic IOP increase 
since most of the patients who showed an IOP elevation 
during hemodialysis also had a shallow anterior chamber 
angle.
2,14-16 Low pCO2 was also reported as a cause.
11 
However, Tawara et al.
17 and Seo et al.
18 showed that a 
pCO2 elevation was not significant during hemodialysis and 
that neither had correlations with IOP. 
The NVG patient initially had an open angle of Grade 4 
using the Shaffer grading system with no peripheral anterior 
synechiae. Although gonioscopy could not be performed after 
the hyphema developed, the patient probably had a crowded 
occluded angle with neovascularization and obstruction of the 
trabecular meshwork with red blood cells. Thus the rapid fall 
in plasma osmolarity and disequilibrium due to hemodialysis 
and decreased aqueous outflow both seem to be the 
mechanism of IOP elevation in this case. We may have been 
given more information if the plasma osmolarity and plasma 
colloid osmotic pressure of the patient had been checked in 
this patient. However, this case is a good example to remind 
physicians of complications associated with hemodialysis.
As a treatment modality, carbonic anhydrase inhibitor has 
long been accepted as the drug of choice in hemodialysis- 
associated IOP elevation. Nevertheless, oral carbonic anhy-
drase inhibitor causes metabolic acidosis which might be fatal 
to patients with end-stage renal disease. Seo et al.
18 admin-
istered an oral hypertonic solution (glycerol) instead and 
showed effective IOP control with less complications in NVG 
and glaucoma patients. The topical carbonic anhydrase 
inhibitor was less effective than the oral administration used 
in their study. Masuda et al.
7 reported that Argon laser 
trabeculoplasty successfully controlled the IOP elevation in 
exfoliative glaucoma patients showing intradialytic IOP 
elevation, while Choong et al.
6 reported that bilateral IOP 
elevation after hemodialysis stabilized with topical β -blocker 
in nonglaucomatous patients. 
In this case, elevated IOP levels during hemodialysis were 
refractory to the treatments. The cause seems to be the 
occlusion of the aqueous outflow due to the neovasculari-
zation of the angle, fibrosis of the Ahmed valve tip, and 
fibrosis of bleb. This was because intradialytic IOP elevations 
were controlled before the formation of the fibrous 
membrane. The patient’s young age and NVG are both 
well-known risk factors of bleb fibrosis and failure.
According to this case, physicians should be aware of the 
possibilities of IOP elevation during hemodialysis in glau-
comatous patients. There have been several studies with 
nonglaucomatous patients, but reports on IOP fluctuations in 
glaucomatous patients under hemodialysis are still limited. So 
far, the influence of hemodialysis on IOP is not clear, and 
even in recent studies opposite findings have been found.
19 
Further evaluations of glaucoma patients under regular 
hemodialysis with information including their osmolarity, 
plasma colloid pressure and gonioscopic findings might be 
meaningful in future studies.
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